Home » Topics » Disease categories and therapies » Dental

Dental
RSS

Canadian marketing clearance granted for Emdogain

Aug. 28, 1997

Pacific Pharmaceuticals and Steri-Oss sign distribution agreement

Aug. 28, 1997

Delmopinol inhibits gingivitis in extreme rates of plaque formation

Aug. 18, 1997

Marketing approval sought for Periostat in Italy

July 25, 1997

Lifecore Biomedical to distribute LifeCell's AlloDerm in U.S.

July 7, 1997

Emdogain approved in South Africa

July 3, 1997

State University of New York grants license to Noven for anticavity compounds

June 4, 1997

Potential new treatments highlighted at recent periodontology symposium

April 28, 1997

Biora introduces Emdogain in the U.S.

April 21, 1997

Atrix submits NDA for Atridox

April 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...